Institute of Personalized Medicine (IPM)

a medical professional


Understanding how variations in the human genome affect the response to medications

Our researchers are working to generate new knowledge, and to develop tools and algorithms that can help in personalizing medicine utilizing a patient’s genetic profile and other factors to achieve maximum therapeutic benefit with minimum toxicity.


human genes DNA model

PGx Conference 2022

Registration for the 2022 UMN Pharmacogenomics (PGx) Conference is open! This virtual event is designed for healthcare professionals interested in implementing PGx tools to provide higher-value care to their clients. Join us Sept. 21-23, 2022. 

For more information, and to register, please visit the PGx 2022 website

University Precision Medicine Initiatives

Institute of Personalized Medicine (IPM) Precision Medicine Initiatives

The University of Minnesota College of Pharmacy is proud to host the nation's first Project ECHO (Extension for Community Healthcare Outcomes) program focused on pharmacogenomics-informed clinical care. Learn more about PGx ECHO

PGx Certificate for Health Professionals in Rural and Underserved Areas

The PGx Clinical Workforce Training Program is currently accepting inquiries for its second cohort! Applications for the 2023 program are due by November 1, 2022.  Learn more about PGx Clinical Workforce Training Program

UMN/ASHP PGx Accelerator Program

The Pharmacogenomics Accelerator program will support clinical leaders, frontline practitioners, and additional team members that are assuming responsibility for pharmacogenomic program implementation in their institutions, as well as those seeking to enhance their baseline clinical skills in pharmacogenomics. Read more about UMN's collaboration with ASHP

Free PGx Testing for Incoming Students

Through a partnership between the University of Minnesota College of Pharmacy and Kailos Genetics, a HudsonAlpha Institute for Biotechnology resident company, College of Pharmacy first-year students will have the unique opportunity to obtain free comprehensive pharmacogenomic testing by Kailos Genetics’ InspexionTM. Learn more about new Pharmacogenetic opportunities

PGx at the Minnesota State Fair

University of Minnesota (UMN) College of Pharmacy (Twin Cities) and UMN Medical School (Duluth) faculty, students, and staff teamed up at the 2021 Minnesota State Fair to ask Minnesotans about their beliefs and perceptions regarding the innovative science of pharmacogenomics (PGx) with the "How Do Your Genes Fit?" survey. Learn more about PGx at the Minnesota State Fair


Group photo

On June 15th and 16th, the UMN College of Pharmacy hosted 21 pharmacists from the 2023 cohort of the Applied Pharmacogenomics for the Healthcare Workforce program for a workshop targeting pharmacists working in rural and/or underserved communities.

Maroon background with University of Minnesota block M logo

CSHP's official announcement:

Cindy Luo

Clinical Pharmacy Specialist (Solid Organ Transplant), Vancouver General Hospital, Vancouver, BC

Sabbatical focus: application, integration and implementation of pharmacogenomics (PGx) to clinical pharmacy practice

Maroon background with University of Minnesota block M logo

Pamala Jacobson received the Sara Evans Faculty Woman Scholar/ Leader Award from the University of Minnesota Women’s Center, Office for Equity and Diversity and was honored at their Celebrating Changemakers Awards event on October 11, 2018.

Sam Callisto

Samuel is a PhD Candidate in the Experimental and Clinical Pharmacology department. During his time in the program Samuel has pursued various avenues of research related to precision medicine in neuropharmacology with a focus on anti-seizure drugs.

Jay Wen

Jay's research focuses on the determination of known genetic variations within Very Important Pharmacogenes (VIPs) in the Hmong population which brings local, state-wide and regional relevance to the nationally supported NIH “Precision Medicine Initiative”.

person holding cigarette

U scientists are teaming up with the Mille Lacs Band of Ojibwe to investigate aspects of lung cancer and nicotine metabolism from commercial tobacco use that may be unique to the American Indian populations.

Contact Us

Institute of Personalized Medicine (IPM)

Pamala Jacobson, PharmD, FCCP, Director